cabergoline has been researched along with Erectile Dysfunction in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akirov, A; Barzilay-Yoseph, L; Eizenberg, Y; Fraenkel, M; Friedrich, I; Herzberg, D; Hirsch, D; Ishay, A; Livner, A; Manisterski, Y; Masri, H; Robenshtok, E; Shimon, I; Tsvetov, G; Yoel, U | 1 |
Chatterjee, S; Das, A; Maiti, A | 1 |
Anand, KS; Dhikav, V | 1 |
Altomare, M; Colosimo, C; Corsello, SM; Lovicu, RM; Migneco, MG; Rota, CA; Ubertini, G | 1 |
Colao, A; De Rosa, M; Di Somma, C; Lombardi, G; Orio, F; Tauchmanova', L; Vitale, G; Zarrilli, S | 1 |
Christ, ER; Jenni, S; Seiler, R; Stettler, C | 1 |
Coppola, A; Cuomo, MA | 1 |
1 review(s) available for cabergoline and Erectile Dysfunction
Article | Year |
---|---|
[Prolactinoma in the male. Physiopathological, clinical, and therapeutic features].
Topics: Cabergoline; Cranial Irradiation; Dopamine Agonists; Erectile Dysfunction; Ergolines; Galactorrhea; Gynecomastia; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Male; Libido; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome | 1998 |
1 trial(s) available for cabergoline and Erectile Dysfunction
Article | Year |
---|---|
Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence.
Topics: Adult; Cabergoline; Case-Control Studies; Circadian Rhythm; Dopamine Agonists; Drug Administration Schedule; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Longitudinal Studies; Male; Middle Aged; Penile Erection; Testosterone; Treatment Outcome | 2004 |
5 other study(ies) available for cabergoline and Erectile Dysfunction
Article | Year |
---|---|
Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cabergoline; Cohort Studies; Erectile Dysfunction; Humans; Hyperprolactinemia; Israel; Male; Osteoporosis; Prolactin; Prolactinoma; Retrospective Studies; Testosterone; Treatment Outcome | 2019 |
A man with breast discharge and headache.
Topics: Adult; Brain; Cabergoline; Dopamine Agonists; Erectile Dysfunction; Ergolines; Headache; Humans; Magnetic Resonance Imaging; Male; Nipple Discharge; Pituitary Neoplasms; Prolactinoma | 2016 |
Hyperprolactinemia: an unusual cause of erectile dysfunction.
Topics: Adenoma; Adult; Cabergoline; Dopamine Agonists; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Treatment Outcome | 2013 |
Giant prolactinomas in men: efficacy of cabergoline treatment.
Topics: Adrenal Glands; Adult; Aged; Antineoplastic Agents; Cabergoline; Erectile Dysfunction; Ergolines; Humans; Hypothyroidism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders | 2003 |
[Simultaneous defect of visual fields and loss of libido--a coincidence?].
Topics: Cabergoline; Diagnosis, Differential; Dopamine Agonists; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Hypogonadism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Compression Syndromes; Optic Nerve Diseases; Pituitary Neoplasms; Prolactinoma; Visual Fields | 2006 |